HIV

Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges
Bill Gates Reflects On Nelson Mandela's Efforts: 'Global Health Stands On The Shoulders Of His Immense Legacy'
Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges
Bill Gates Reflects On Nelson Mandela's Efforts: 'Global Health Stands On The Shoulders Of His Immense Legacy'
EXCLUSIVE: Blockchain-Powered Project Targeting HIV Treatment In Africa Raises $2M From VCs
Are HIV Patients Who Use Cannabis At Greater Risk For Heart Disease? This Cardiologist Was Granted $2.3M To Find Out

HIV Recent News

Did Umbilical Cord Blood Transplant Help Cure A Woman's HIV infection?
A woman in the New York City area appears to have been cured of an HIV infection, Wall Street Journal reported, provid
IAVI, Moderna Kickstart HIV Vaccine Antigens Trial Delivered Through mRNA Technology
IAVI, the nonprofit scientific research organization, and Moderna Inc (NASDAQ: MRNA) have 
Proceeds From Apple's RED Gizmos To Be Used To Fight COVID-19 In Sub-Saharan Africa
Apple Inc (NASDAQ: AAPL) said it would donate half the proceeds arising out of the sales of its (PRODUCT) RED sales to Global Fund for the fight against COVID-19 in sub-Saharan Africa.
Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option
Merck Stops Enrollment In Two Islatravir Trials For Prevention Of HIV Infection
After the external data monitoring committee's recommendation, Merck & Co Inc (NYSE: MRK) has 
Merck Pauses Development Of MK-8507 In HIV Infection
ViiV Healthcare's Dovato Combo Regime Shows Encouraging Long Term Data In HIV Patients
Theratechnologies' IV Push Form Of HIV Treatment At Par With IV Infusion
Why Are Indaptus Therapeutics Shares Shooting Higher On Wednesday?
Johnson & Johnson Stops HIV Vaccine Trial In African Women
Merck Discloses New Islatravir Data Supporting Safety Profile For PrEP Regime For HIV Infection
Four-Year Biktarvy Data Show High Efficacy, Durable Viral Suppression In Untreated HIV Patients
Gilead's Lenacapavir Shows High Rates Of Virologic Suppression In Heavily Treated HIV Patients
Abbott Announces HIV Vaccine Research Findings: 'Another Step Toward Unlocking A Cure'
Abbott Laboratories (NYSE: ABT) has announced a potential research breakthrough that could lead to advancements and potential vaccines for the treatment of HIV.
Pfizer, GSK-Backed ViiV First To Get FDA Approval For Injectable Drug To Treat HIV
In a first, a monthly injectable HIV drug made by a GlaxoSmithKline plc (NYSE: GSK)- and Pfizer Inc (NYSE: PFE)-owned company has received the approval of the United States Food and Drug Administration.
GlaxoSmithKline's ViiV Healthcare Bags EU Marketing Authorization For Long-Acting HIV Treatment
British pharmaceutical company GlaxoSmithKline PLC’s (NYSE: GSK) majority-owned subsidiary ViiV Healthcare received the marketing authorization approval for
Study: ViiV Healthcare's 2-Drug HIV Regimen As Effective As 3
Gilead, Lyndra Therapeutics Partner On Ultra-Long-Acting HIV Drugs
Raymond James Reviews Gilead Pipelines, Takes Bullish Stance On Pharma Stock
Jefferies On Gilead: 'We See Better Days Ahead'
Mylan Price Target Slashed Even As TLD Drug Receives Tentative Approval
Healthcare Repeal Bad For GlaxoSmithKline, Other HIV Treatment Stocks
Gates Foundation Deal Opens Things Up For OraSure
;

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved